As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments

Dr. Nunez Smith stated that the administration is still available to help states, territories, and jurisdictions throughout the country in order to connect more people to the treatments. However, she stressed that vaccination was still the best way to prevent Covid-19.Jeffrey D. Zients is the White House's Covid-19 response coordinator. He said that the Biden administration had deployed more than 500 federal employees to assist state hospitals and health departments in combating the Delta variant. This included emergency medical personnel in Louisiana and Mississippi, as well as Centers for Disease Control and Prevention teams from Tennessee, Illinois, and Missouri.Dr. Nunez Smith said that the administration has conducted virtual trainings for health system officials and doctors in Arizona, Nevada and Utah on how to administer the drug. Federal teams in Arizona are providing the treatment at two locations, where none the Covid-19 patients have been admitted.Federal government funds the treatments and gives them away to patients. They mimic the natural immune system antibodies to fight coronavirus. These treatments have been proven to dramatically reduce hospitalizations, and even death rates when administered to patients as soon as symptoms begin. They are usually administered intravenous. They may also be able prevent certain cases of the disease completely in some people who have been exposed to the virus. The antibody treatments are more effective than coronavirus vaccines which can take up to six weeks to give full protection. They can also be administered to patients already ill with a faster effect.According to the Department of Health and Human Services, just half of the treatment's distributed supply has been used by over 6,000 hospitals and other providers since late last year. The federal government relies upon providers and state health departments for reporting their usage numbers. It does not track the demographics or patients who have received the drugs.